• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer.

作者信息

Hoshi Senji, Ohyama Chikara, Hagisawa Shigeru, Ono Kunio, Satoh Makoto, Saito Seiichi, Fukuzaki Atushi, Arai Yoichi

机构信息

Department of Urology, Yamagata Prefectural Hospital, 1800 Aoyagi, Yamagata 990-2292, Japan.

出版信息

Int J Clin Oncol. 2003 Apr;8(2):118-20. doi: 10.1007/s101470300021.

DOI:10.1007/s101470300021
PMID:12720106
Abstract

Many types of chemotherapy are now being attempted all over the world for hormone-refractory prostate cancer (HRPC) patients, and prostate-specific antigen (PSA) reduction in almost half of the treated patients has been reported. However, only a few studies have reported the response of bone metastasis. The authors report a patient with HRPC who obtained complete regression of bone metastases on super bone scan by biochemical modulation (BM), dexamethasone, and endocrine therapy.

摘要

相似文献

1
Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer.
Int J Clin Oncol. 2003 Apr;8(2):118-20. doi: 10.1007/s101470300021.
2
[Low-dose cisplatin and UFT for hormone refractory prostate cancer].
Gan To Kagaku Ryoho. 2002 Oct;29(10):1773-8.
3
[Inhibition of prostate cancer growth in nude mice by hormone and chemotherapy].[激素与化疗对裸鼠前列腺癌生长的抑制作用]
Gan To Kagaku Ryoho. 1996 Sep;23(10):1335-8.
4
Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer.环磷酰胺、尿嘧啶加替加氟与雌莫司汀口服联合用于激素难治性前列腺癌
Oncology. 2001;60(1):49-54. doi: 10.1159/000055296.
5
Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.特异性内皮素-A受体拮抗剂ZD4054在无痛或症状轻微的激素抵抗性前列腺癌和骨转移患者中的安全性和有效性：一项双盲、安慰剂对照、随机2期试验。
Eur Urol. 2009 May;55(5):1112-23. doi: 10.1016/j.eururo.2008.11.002. Epub 2008 Nov 29.
6
Role of estrogens in the secondary hormonal manipulation of hormone refractory prostate cancer.
J Pak Med Assoc. 2004 Sep;54(9):445-7.
7
The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer.阿霉素和表阿霉素在转移性激素难治性前列腺癌患者治疗中的作用。
Cancer Treat Rev. 2008 Dec;34(8):710-8. doi: 10.1016/j.ctrv.2008.05.004. Epub 2008 Jul 11.
8
Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.生长抑素类似物、地塞米松与标准雄激素剥夺疗法联合用于伴有骨转移的D3期前列腺癌患者
Clin Cancer Res. 2004 Jul 1;10(13):4398-405. doi: 10.1158/1078-0432.CCR-04-0077.
9
Endocrine plus uracil/tegafur therapy for prostate cancer.内分泌联合尿嘧啶/替加氟治疗前列腺癌。
Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):120-4.
10
[Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].[以化学激素疗法作为D2期前列腺癌初始治疗的临床评估——优福定联合激素疗法的疗效]
Gan To Kagaku Ryoho. 1995 Jan;22(1):105-9.

引用本文的文献

1
PKA compartmentalization via AKAP220 and AKAP12 contributes to endothelial barrier regulation.通过A激酶锚定蛋白220（AKAP220）和A激酶锚定蛋白12（AKAP12）实现的蛋白激酶A（PKA）区室化有助于内皮屏障调节。
PLoS One. 2014 Sep 4;9(9):e106733. doi: 10.1371/journal.pone.0106733. eCollection 2014.
2
Efficacy of tegafur-uracil (UFT) administration in castration-resistant prostate cancer patients with a history of both alternative antiandrogen therapy and estramustine phosphate sodium hydrate therapy.替加氟-尿嘧啶（UFT）给药对既往接受过替代抗雄激素治疗和磷酸雌莫司汀水合物治疗的去势抵抗性前列腺癌患者的疗效。
Int Urol Nephrol. 2014 Jun;46(6):1123-9. doi: 10.1007/s11255-013-0634-5. Epub 2013 Dec 20.
3
Complete regression of advanced prostate cancer for ten years: A case report and review of the literature.
晚期前列腺癌十年完全缓解：一例病例报告及文献综述
Oncol Lett. 2013 Aug;6(2):590-594. doi: 10.3892/ol.2013.1377. Epub 2013 Jun 6.
4
Inhibition of XO or NOX attenuates diethylstilbestrol-induced endothelial nitric oxide deficiency without affecting its effects on LNCaP cell invasion and apoptosis.XO 或 NOX 的抑制作用可减轻己烯雌酚诱导的内皮型一氧化氮合酶缺乏，但不影响其对 LNCaP 细胞侵袭和凋亡的作用。
Clin Sci (Lond). 2012 Oct;123(8):509-18. doi: 10.1042/CS20110407.